Menu

Former NSF Director Dies

Erich Bloch, a Holocaust refugee who rose to prominence as director of the National Science Foundation, has passed away at age 91.

Dec 5, 2016
Joshua A. Krisch

Erich BlochNSF

Erich Bloch, who stood at the helm of the National Science Foundation (NSF) from 1984 to 1990, died on November 25 at age 91. From humble beginnings in a Swiss refugee camp, Bloch’s illustrious career in science management took him from the upper echelons of IBM to the helm of NSF, where he advocated for science during the Reagan administration.

“He was probably the best government manager ever, certainly at NSF,” Gordon Bell, one of Bloch’s former colleagues at the agency, told Science.

After losing both of his parents in the Holocaust, Bloch survived the war in a Swiss refugee camp and immigrated to the United States in 1948 when he was 23 years old. Just four years later Bloch started working for IBM where, in 1964, he managed the development of the IBM mainframe System 360, arguably the precursor to modern operating systems. “The system enabled IBM to dominate the computer market for a quarter-century,” The New York Times wrote in an obituary.

When President Ronald Reagan tapped Bloch to lead the NSF in 1984, he became the first director of the agency to ever be appointed without having a PhD. But he quickly demonstrated his commitment to the scientific community and his agency. Likely due to his background with IBM, Bloch invested much of his political capital into creating a directorate for computer science within NSF, which supported the rise of computer science as a field of study. “If Erich hadn’t been there, it would have been another decade before computing got to this point,” Bell told Science.

After stepping down from his position at the NSF, Bloch went on to join the Council on Competitiveness and received a number of science awards including the National Medal of Technology and Innovation. But despite leaving public service, Bloch never ceased to advocate for the importance of science in society.

“Members of Congress, lawyers, and MBAs are not going to improve our competitive standing in the world,” Bloch wrote to Representative Howard Wolpe (D–MI) in 1991. “Scientists and engineers just might.”

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
NRGene has launched a new product that aims to empower breeding and maximize agricultural yield as part of the Denovo assembly product suite offered by the company.
Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!